Literature DB >> 23078273

Neuroimaging comparison of primary progressive apraxia of speech and progressive supranuclear palsy.

J L Whitwell1, J R Duffy, E A Strand, M M Machulda, M L Senjem, J L Gunter, K Kantarci, S D Eggers, C R Jack, K A Josephs.   

Abstract

BACKGROUND AND
PURPOSE: Primary progressive apraxia of speech, a motor speech disorder of planning and programming, is a tauopathy that has overlapping histological features with progressive supranuclear palsy. We aimed to compare, for the first time, atrophy patterns, as well as white matter tract degeneration, between these two syndromes.
METHODS: Sixteen primary progressive apraxia of speech subjects were age- and gender-matched to 16 progressive supranuclear palsy subjects and 20 controls. All subjects were prospectively recruited, underwent neurological and speech evaluations and 3.0-Tesla magnetic resonance imaging. Grey and white matter atrophy was assessed using voxel-based morphometry and atlas-based parcellation, and white matter tract degeneration was assessed using diffusion tensor imaging.
RESULTS: All progressive supranuclear palsy subjects had typical oculomotor/gait impairments, but none had speech apraxia. Both syndromes showed grey matter loss in supplementary motor area, white matter loss in posterior frontal lobes and degeneration of the body of the corpus callosum. Whilst lateral grey matter loss was focal, involving superior premotor cortex, in primary progressive apraxia of speech, loss was less focal extending into prefrontal cortex in progressive supranuclear palsy. Caudate volume loss and tract degeneration of superior cerebellar peduncles were also observed in progressive supranuclear palsy. Interestingly, area of the midbrain was reduced in both syndromes compared to controls, although this was greater in progressive supranuclear palsy.
CONCLUSIONS: Although neuroanatomical differences were identified between these distinctive clinical syndromes, substantial overlap was also observed, including midbrain atrophy, suggesting these two syndromes may have common pathophysiological underpinnings.
© 2012 The Author(s) European Journal of Neurology © 2012 EFNS.

Entities:  

Mesh:

Year:  2012        PMID: 23078273      PMCID: PMC3556348          DOI: 10.1111/ene.12004

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  37 in total

Review 1.  Voxel-based morphometry--the methods.

Authors:  J Ashburner; K J Friston
Journal:  Neuroimage       Date:  2000-06       Impact factor: 6.556

2.  Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain.

Authors:  N Tzourio-Mazoyer; B Landeau; D Papathanassiou; F Crivello; O Etard; N Delcroix; B Mazoyer; M Joliot
Journal:  Neuroimage       Date:  2002-01       Impact factor: 6.556

Review 3.  Advances in functional and structural MR image analysis and implementation as FSL.

Authors:  Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews
Journal:  Neuroimage       Date:  2004       Impact factor: 6.556

Review 4.  Gait apraxia after bilateral supplementary motor area lesion.

Authors:  S Della Sala; A Francescani; H Spinnler
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-01       Impact factor: 10.154

5.  The FAB: a Frontal Assessment Battery at bedside.

Authors:  B Dubois; A Slachevsky; I Litvan; B Pillon
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

6.  Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy brain bank.

Authors:  Keith A Josephs; Dennis W Dickson
Journal:  Mov Disord       Date:  2003-09       Impact factor: 10.338

7.  Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy.

Authors:  C Brenneis; K Seppi; M Schocke; T Benke; G K Wenning; W Poewe
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-02       Impact factor: 10.154

8.  Progression of gait, speech and swallowing deficits in progressive supranuclear palsy.

Authors:  Christopher G Goetz; Sue Leurgans; Anthony E Lang; Irene Litvan
Journal:  Neurology       Date:  2003-03-25       Impact factor: 9.910

9.  Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech.

Authors:  Keith A Josephs; Joseph R Duffy; Edythe A Strand; Mary M Machulda; Matthew L Senjem; Ankit V Master; Val J Lowe; Clifford R Jack; Jennifer L Whitwell
Journal:  Brain       Date:  2012-03-01       Impact factor: 13.501

10.  Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson's disease.

Authors:  Shona Price; Dominic Paviour; Rachael Scahill; John Stevens; Martin Rossor; Andrew Lees; Nick Fox
Journal:  Neuroimage       Date:  2004-10       Impact factor: 6.556

View more
  22 in total

1.  Tracking the development of agrammatic aphasia: A tensor-based morphometry study.

Authors:  Jennifer L Whitwell; Joseph R Duffy; Mary M Machulda; Heather M Clark; Edythe A Strand; Matthew L Senjem; Jeffrey L Gunter; Anthony J Spychalla; Ronald C Petersen; Clifford R Jack; Keith A Josephs
Journal:  Cortex       Date:  2016-09-30       Impact factor: 4.027

2.  Sample size calculations for clinical trials targeting tauopathies: a new potential disease target.

Authors:  Jennifer L Whitwell; Joseph R Duffy; Edythe A Strand; Mary M Machulda; Nirubol Tosakulwong; Stephen D Weigand; Matthew L Senjem; Anthony J Spychalla; Jeffrey L Gunter; Ronald C Petersen; Clifford R Jack; Keith A Josephs
Journal:  J Neurol       Date:  2015-06-17       Impact factor: 4.849

3.  Prosodic and phonetic subtypes of primary progressive apraxia of speech.

Authors:  Rene L Utianski; Joseph R Duffy; Heather M Clark; Edythe A Strand; Hugo Botha; Christopher G Schwarz; Mary M Machulda; Matthew L Senjem; Anthony J Spychalla; Clifford R Jack; Ronald C Petersen; Val J Lowe; Jennifer L Whitwell; Keith A Josephs
Journal:  Brain Lang       Date:  2018-07-04       Impact factor: 2.381

4.  Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology.

Authors:  J L Whitwell; C R Jack; J E Parisi; J L Gunter; S D Weigand; B F Boeve; J E Ahlskog; R C Petersen; D W Dickson; K A Josephs
Journal:  Eur J Neurol       Date:  2013-06-07       Impact factor: 6.089

5.  Tau-PET imaging with [18F]AV-1451 in primary progressive apraxia of speech.

Authors:  Rene L Utianski; Jennifer L Whitwell; Christopher G Schwarz; Matthew L Senjem; Nirubol Tosakulwong; Joseph R Duffy; Heather M Clark; Mary M Machulda; Ronald C Petersen; Clifford R Jack; Val J Lowe; Keith A Josephs
Journal:  Cortex       Date:  2018-01-02       Impact factor: 4.027

Review 6.  Magnetic resonance imaging for the diagnosis of Parkinson's disease.

Authors:  Beatrice Heim; Florian Krismer; Roberto De Marzi; Klaus Seppi
Journal:  J Neural Transm (Vienna)       Date:  2017-04-04       Impact factor: 3.575

7.  Prominent auditory deficits in primary progressive aphasia: A case study.

Authors:  Rene L Utianski; Joseph R Duffy; Heather M Clark; Mary M Machulda; Dennis W Dickson; Jennifer L Whitwell; Keith A Josephs
Journal:  Cortex       Date:  2019-02-21       Impact factor: 4.027

8.  Ecological validity and neuroanatomical correlates of the NIH EXAMINER executive composite score.

Authors:  Katherine L Possin; Amanda K LaMarre; Kristie A Wood; Dan M Mungas; Joel H Kramer
Journal:  J Int Neuropsychol Soc       Date:  2013-06-14       Impact factor: 2.892

9.  The evolution of parkinsonism in primary progressive apraxia of speech: A 6-year longitudinal study.

Authors:  Zeynep Idil Seckin; Joseph R Duffy; Edythe A Strand; Heather M Clark; Rene L Utianski; Mary M Machulda; Hugo Botha; Farwa Ali; Nha Trang Thu Pham; Val J Lowe; Jennifer L Whitwell; Keith A Josephs
Journal:  Parkinsonism Relat Disord       Date:  2020-10-07       Impact factor: 4.891

10.  Longitudinal flortaucipir ([18F]AV-1451) PET imaging in primary progressive apraxia of speech.

Authors:  Rene L Utianski; Peter R Martin; Hugo Botha; Christopher G Schwarz; Joseph R Duffy; Ronald C Petersen; David S Knopman; Heather M Clark; Alissa M Butts; Mary M Machulda; Clifford R Jack; Val J Lowe; Jennifer L Whitwell; Keith A Josephs
Journal:  Cortex       Date:  2019-11-19       Impact factor: 4.027

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.